136 related articles for article (PubMed ID: 31612019)
1. Different responses to anti-programmed cell death protein 1 (PD-1) immunotherapy in a patient with Lynch syndrome and metachronous urothelial and colon cancer: A case report.
Feng Y; Cao Y; Yuan M; Chen R; Ji X; Hu X
Oncol Lett; 2019 Nov; 18(5):5085-5090. PubMed ID: 31612019
[TBL] [Abstract][Full Text] [Related]
2. Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer.
Salman P; Panay S; Fernández R; Mahave M; Soza-Ried C
Onco Targets Ther; 2018; 11():7295-7300. PubMed ID: 30425520
[TBL] [Abstract][Full Text] [Related]
3. Dual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD-1/PDL-1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch Syndrome, Metastatic Colon, and Localized Urothelial Cancer.
Winer A; Ghatalia P; Bubes N; Anari F; Varshavsky A; Kasireddy V; Liu Y; El-Deiry WS
Oncologist; 2019 Nov; 24(11):1416-1419. PubMed ID: 31444293
[TBL] [Abstract][Full Text] [Related]
4. A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome.
Oki R; Urasaki T; Ueki A; Inamura K; Komai Y; Takahashi S; Yonese J; Yuasa T
IJU Case Rep; 2023 Jan; 6(1):33-36. PubMed ID: 36605683
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.
Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T
Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703
[TBL] [Abstract][Full Text] [Related]
6. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
[TBL] [Abstract][Full Text] [Related]
7. Total colectomy for multiple metachronous colon cancers in a patient with Lynch syndrome.
Kochi M; Shimomura M; Hinoi T; Niitsu H; Yano T; Mukai S; Sawada H; Miguchi M; Saito Y; Adachi T; Ishizaki Y; Egi H; Ohdan H
Surg Case Rep; 2015 Dec; 1(1):78. PubMed ID: 26380806
[TBL] [Abstract][Full Text] [Related]
8. Discordant Mismatch Repair Protein Immunoreactivity in Lynch Syndrome-Associated Neoplasms: A Recommendation for Screening Synchronous/Metachronous Neoplasms.
Roth RM; Haraldsdottir S; Hampel H; Arnold CA; Frankel WL
Am J Clin Pathol; 2016 Jul; 146(1):50-6. PubMed ID: 27357288
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma.
Roncati L
Acta Dermatovenerol Croat; 2018 Dec; 26(4):341-343. PubMed ID: 30665488
[TBL] [Abstract][Full Text] [Related]
11. PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors.
Sloan EA; Ring KL; Willis BC; Modesitt SC; Mills AM
Am J Surg Pathol; 2017 Mar; 41(3):326-333. PubMed ID: 27984238
[TBL] [Abstract][Full Text] [Related]
12. Genetics, diagnosis and treatment of Lynch syndrome: Old lessons and current challenges.
Duraturo F; Liccardo R; De Rosa M; Izzo P
Oncol Lett; 2019 Mar; 17(3):3048-3054. PubMed ID: 30867733
[TBL] [Abstract][Full Text] [Related]
13. Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type.
Maccaroni E; Lenci E; Agostinelli V; Cognigni V; Giampieri R; Mazzanti P; Di Pietro Paolo M; Bianchi F; Brugiati C; Belvederesi L; Pagliaretta S; Mandolesi A; Scarpelli M; Murrone A; Morgese F; Ballatore Z; Berardi R
Explor Target Antitumor Ther; 2021; 2(3):240-248. PubMed ID: 36046437
[TBL] [Abstract][Full Text] [Related]
14. Rationale for evaluating breast cancers of Lynch syndrome patients for mismatch repair gene expression.
Sorscher S
Breast Cancer Res Treat; 2019 Nov; 178(2):469-471. PubMed ID: 31392519
[TBL] [Abstract][Full Text] [Related]
15. Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability.
Messick CA; Kravochuck S; Church JM; Kalady MF
Dis Colon Rectum; 2014 Jan; 57(1):39-46. PubMed ID: 24316944
[TBL] [Abstract][Full Text] [Related]
16. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
Ponti G; Manfredini M; Tomasi A; Pellacani G
Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
[TBL] [Abstract][Full Text] [Related]
17. Lynch syndrome and exposure to aristolochic acid in upper-tract urothelial carcinoma: its clinical impact?
Colin P; Seisen T; Mathieu R; Shariat SF; Rouprêt M
Transl Androl Urol; 2016 Oct; 5(5):648-654. PubMed ID: 27785421
[TBL] [Abstract][Full Text] [Related]
18. Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.
Joost P; Therkildsen C; Dominguez-Valentin M; Jönsson M; Nilbert M
Urology; 2015 Dec; 86(6):1212-7. PubMed ID: 26385421
[TBL] [Abstract][Full Text] [Related]
19. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
20. Lynch Syndrome: A Primer for Urologists and Panel Recommendations.
Mork M; Hubosky SG; Rouprêt M; Margulis V; Raman J; Lotan Y; O'Brien T; You N; Shariat SF; Matin SF
J Urol; 2015 Jul; 194(1):21-9. PubMed ID: 25711197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
